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Abstract: In recent years, functional nanoprobes with multiple imaging modalities have become an
emerging field of biomedical research. In this preliminary study, we utilized a facile hydrothermal
method for the preparation of magneto-fluorescent bimodal carbon dots doped with dysprosium
(Dy-CDs). The prepared Dy-CDs have shown a good colloidal stability in a water solution and strong
blue–green fluorescence, with a maximum at 452 nm. In addition, the excellent transverse relaxivity of
the prepared Dy-CDs (r2 = 7.42 ± 0.07 mM−1s−1) makes them also suitable for T2-weighted magnetic
resonance imaging (MRI). Thus, synthesized Dy-CDs could be potentially utilized for both MRI and
fluorescence imaging of living cells.
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1. Introduction
The development of new nanoscale contrast agents is a promising areas of research in the
field of nanomedicine. In particular, these multifunctional nanoprobes can be more accurate than
their molecular counterparts, because of the greatly improved image contrast. To date, various
nanostructures, such as Fe3O4 [1,2], MnO [3] and various lanthanide oxides [4–7], have been
successfully tested as new bimodal nanoprobes for magnetic resonance (MR) and fluorescence imaging
of living cells. On the other hand, the toxicity concerns of these inorganic nanoprobes limit their
wide usage in medical applications. To solve the toxicity issue, an appropriate surface coating
should be employed with an organic layer [8], or with some inert materials, such as carbon [9]
and silica [10]. However, surface modifications may affect the relaxivity properties of paramagnetic
nanoprobes and, as a result, reduce the image contrast [10]. Therefore, one can use a different
strategy where the paramagnetic ions are introduced into a matrix of some biocompatible material.
Paramagnetic Gd3+ has been incorporated into biocompatible materials such as hydroxyapatite [11],
zirconia [12], and carbon [13,14]. Correspondingly, the region of interest on MRI imaging can be
brighter (positive agent) because of the longitudinal relaxation that is caused by the presence of
gadolinium ions. On the other hand, the negative contrast agents are more effective for bone marrow,
liver, and spleen contrast enhancement [2,15]. Negative contrast nanoprobes can be prepared using
a biocompatible material that has been doped with dysprosium or holmium ions [4,16]. These
nanoprobes can generate strong MR signals thanks to the high magnetic moments of the Dy3+ and
Ho3+ ions and the larger density of the magnetic ions per surface area. In this study, to the best of
our knowledge, we present the first report on the synthesis and analysis of carbon dots doped with
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dysprosium (Dy-CDs) ions. Thus, the main aim of this study is to demonstrate the applicability of the
magneto-fluorescent Dy-CDs for simultaneous MR and optical imaging of living cells.
2. Experimental
2.1. Synthesis Process
Analytical grade dextrose C6H12O6 (≥99.5%) and dysprosium (III) chloride hexahydrate DyCl3
× 6H2O (99.9%) were purchased from Sigma-Aldrich (St. Louis, MO, USA) and were used as they
were received. The carbon nanodots were prepared according to the reported protocols with some
modification [17,18]. The solution was prepared by dissolving 2 g of dextrose in 30 mL of deionized
(DI) water and was mixed with 0.1 mM of DyCl3 × 6H2O under continuous stirring. Next, the
prepared mixtures were sealed and heated at 190 ◦C for 2 h. The obtained light-yellow solutions were
centrifuged at 12,000 rpm for 30 min. To eliminate the unreacted products, the collected Dy-CDs
were purified by dialysis in DI water for 12 h. The recollected Dy-CDs were dispersed in DI water
for measurements.
2.2. Characterization
The transmission electron microscopy (TEM, JEM-2100, JEOL Ltd., Tokyo, Japan) was
utilized to study the morphology of the Dy-CDs. The dynamic light scattering (DLS) size
measurements were performed using a Nano ZS Zetasizer (Malvern Instruments Ltd., Malvern, UK).
The photoluminescence (PL) excitation and emission spectra of the Dy-CDs were measured using
a fluorescence spectrophotometer (Hitachi F-7000, Hitachi Ltd., Tokyo, Japan). The T2-weighted
images were obtained using a 1.5 T small animal MRI scanner (Siemens Healthinners, Enlargen,
Germany). The measurement parameters that were used were as follows: repetition time/echo
time (TR/TE) = 2009 ms/9 ms, field of view (FOV) = 160 mm × 160 mm, slice thickness = 5 mm,
matrix = 256 × 256, and number of excitations (NEX) = 1. All of the measurements were performed at
a room temperature of 22 ± 1 ◦C.
3. Results and Discussion
The dissolved Dy3+ ions could be embedded in the carbon nanoprobes to form the paramagnetic
Dy-CDs. According to our preliminary results, the size of these nanoprobes could be varied by
changing the reaction time, reaction temperature, and dextrose concentration. The reaction time and
concentration of the precursors were optimized in this study for the preparation of the fluorescent
Dy-CDs with a high transverse relaxivity value. Figure 1 shows the size-distribution and a typical
TEM image (inset) of synthesized Dy-CDs. One can see that the prepared Dy-CDs exhibited a nearly
spherical shape, with the mean sizes in the range of 12–17 nm. In addition, it should be noted that the
prepared Dy-CDs were highly dispersible in an aqueous solution and maintain colloidal stability for
several months.
The optical properties of the prepared Dy-CDs solution were analyzed using a PL spectroscopy.
Figure 2 shows the typical PL excitation and emission spectra of the Dy-CDs solution. One can see that
the aqueous solution of the Dy-CDs appeared to be light-brown colored and transparent (Figure 2 inset).
The prepared Dy-CDs solution exhibited an excitation-dependent emission, which was a characteristic
feature for all of the carbon dots (not shown here). The excitation peak of the Dy-CDs solution reached
the maximum value at ~363 nm. Upon a direct 363 nm excitation, the Dy-CDs solution showed the
broad blue–green emission peak (Figure 2 inset) with a maximum at 452 nm. It should be mentioned
that the excitation and emission peaks of the Dy-CDs solutions were red-shifted compared to the
reported studies [13,14]. This red-shift was most likely as a result of the Dy and Cl doping during the
synthesis process. The quantum yield (QY) of the prepared Dy-CDs solutions were measured using a
quinine bisulfate solution, as the standard was 6.7%. Thus, the prepared Dy-CDs ccould be utilized for
the fluorescence imaging of living cells [13,14].
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Figure 1. Size-distribution and transmission electron microscopy (TEM) image (scale bar = 20 nm) of 
prepared carbon dots doped with dysprosium (Dy-CDs). 
 
Figure 2. Photoluminescence (PL) excitation and emission spectra of the prepared Dy-CDs. Inset is a 
digital photo of the Dy-CDs aqueous solution, taken under daylight (left) and 365 nm UV light 
(right). 
A small animal MRI scanner was used further in order to confirm the ability of the Dy-CDs that 
were to be used as contrast agents. It should be noted that the transverse relaxation was not 
observed in the undoped carbon dots. Figure 3 shows the 1/T2 curve that was measured as a function 
of the total Dy3+ concentration. The transverse relaxivity rate (r2) was estimated from a linear fit of 
1/T2 vs. the Dy3+ concentration. According to the linear fitting, the r2 was calculated to be 7.42 ± 0.07 
mM−1s−1. The obvious darkening of the imaging site (Figure 3 inset) confirmed that the Dy3+ ions 
were successfully introduced into the carbon dots and that the Dy-CDs could be used as a promising 
negative contrast agent. The Dy3+ and Ho3+ based contrast agents were especially suitable for high 
magnetic fields, because the r2 value would increase with the increasing the magnetic field [16]. On 
the other hand, it was necessary to check how the variations of the Dy3+ doping concentrations 
Figure 1. Size-distribution and transmission electron microscopy (TEM) image (scale bar = 20 nm) of
prepared carbon dots doped with dysprosium (Dy-CDs).
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Fi ure 2. Photoluminescence (PL) excitation and emission spectra of the prepared Dy-CDs. Inset is a
digital photo of the Dy-CDs aqueous solution, taken under daylight (left) and 365 nm UV light (right).
A small animal MRI scanner was used further in order to confirm the ability of the Dy-CDs
that were to be used as contrast agents. It should be noted that the transverse relaxation was not
observed in the undoped carbon dots. Figure 3 shows the 1/T2 curve that was measured as a function
of the total y + concentration. The transverse relaxivity rate (r2) as estimated from a linear fit
of 1/T2 vs. the Dy3+ concentration. According to the linear fitting, the r2 was calculated to be
7.42 ± 0.07 mM−1s−1. The obvious darkening of the imaging site (Figure 3 inset) confirmed that the
Dy3+ ions were successfully introduced into the carbon dots and that the Dy-CDs could be used as a
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promising negative contrast agent. The Dy3+ and Ho3+ based contrast agents were especially suitable
for high magnetic fields, because the r2 value would increase with the increasing the magnetic field [16].
On the other hand, it was necessary to check how the variations of the Dy3+ doping concentrations
affected the transverse relaxivity rate of the Dy-CDs. In addition, the toxicity of the Dy-CDs should
have also been tested using several cell lines, despite the fact that the Gd-doped CDs exhibited a low
toxicity [13,14]. We have planned to address the above-mentioned issues in our next full study.
J. Funct. Biomater. 2018, 9, x FOR PEER REVIEW  4 of 5 
 
affected the transverse relaxivity rate of the Dy-CDs. In addition, the toxicity of the Dy-CDs should 
have also been tested using several cell lines, despite the fact that the Gd-doped CDs exhibited a low 
toxicity [13,14]. e have planned to address the above- entioned issues in our next full study. 
 
Figure 3. Transverse relaxation rate (1/T2) vs. Dy3+ concentration (mM). Inset is the transverse 
relaxation images of Dy-CDs solution at different concentrations. 
4. Conclusions 
In summary, the bimodal Dy-doped CDs contrast nanoprobes were prepared using a facile 
hydrothermal synthesis method. The TEM and DLS measurements showed that the average size of 
the prepared Dy-CDs was about 12–17 nm. According to the PL study, the prepared Dy-CDs emitted 
a blue–green emission with a maximum at 452 nm. The MRI measurements of the Dy-CDs revealed 
that the transverse relaxivity rate (r2) value of the sample was 7.42 ± 0.07 mM−1s−1. We strongly 
believe that the prepared bifunctional Dy-CDs can be of great interest for MRI and fluorescence 
imaging of living cells. 
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Figure 3. Transverse relaxation rate (1/T2) vs. Dy3+ concentration (mM). Inset is the transverse
relaxation images of Dy-CDs solution at different concentrations.
4. Conclusions
In summary, the bimodal Dy-doped CDs contrast nanoprobes were prepared using a facile
hydrothermal synthesis method. The TEM and DLS measurements showed that the average size of
the prepared Dy-CDs was about 12–17 nm. According to the PL study, the prepared Dy-CDs emitted a
blue–green emission with a maximum at 452 nm. The MRI measurements of the Dy-CDs revealed that
the transverse relaxivity rate (r2) value of the sample was 7.42 ± 0.07 mM−1s−1. We strongly believe
that the prepared bifunctional Dy-CDs can be of great interest for MRI and fluorescence imaging of
living cells.
Author Contributions: T.S.A. designed the experiments, T.S.A. and .M. performed the synthesis and
characterization of the samples, T.S.A. and Z.P. analyzed the data, and T.S.A. wrote the manuscript.
Acknowledgments: This work was supported by the Social Policy Grant that was provided by Nazarbayev
University to conduct the preliminary research.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Gu, J.; Zhang, W.; Yang, X. Preparation of a superparamagnetic MRI contrast agent with a tumor targeting
function. Mater. Lett. 2013, 94, 8–10. [CrossRef]
2. Atabaev, T.S. PEG-coated superparamagnetic dysprosium-doped Fe3O4 nanoparticles for potential MRI
imaging. BioNanoScience 2018, 8, 299–303. [CrossRef]
3. Chen, N.; Shao, C.; Qu, Y.; Li, S.; Gu, W.; Zheng, T.; Ye, L.; Yu, C. Folic acid-conjugated MnO nanoparticles as
a T1 contrast agent for Magnetic Resonance imaging of tiny brain gliomas. ACS Appl. Mater. Interfaces 2014,
6, 19850–19857. [CrossRef] [PubMed]
J. Funct. Biomater. 2018, 9, 35 5 of 5
4. Norek, M.; Kampert, E.; Zeitler, U.; Peters, J.A. Tuning of the size of Dy2O3 nanoparticles for optimal
performance as an MRI contrast agent. J. Am. Chem. Soc. 2008, 130, 5335–5340. [CrossRef] [PubMed]
5. Atabaev, T.S.; Lee, J.H.; Han, D.-W.; Kim, H.-K.; Hwang, Y.-H. Ultrafine PEG-capped gadolinia nanoparticles:
Cytotoxicity and potential biomedical applications for MRI and luminescent imaging. RSC Adv. 2014, 4,
34343–34349. [CrossRef]
6. Atabaev, T.; Lee, J.; Shin, Y.; Han, D.-W.; Choo, K.; Jeon, U.; Hwang, J.; Yeom, J.; Kim, H.-K.; Hwang, Y.-H. Eu,
Gd-Codoped Yttria Nanoprobes for Optical and T1-Weighted Magnetic Resonance Imaging. Nanomaterials
2017, 7, 35. [CrossRef] [PubMed]
7. Xu, W.; Kattel, K.; Park, J.Y.; Chang, Y.; Kim, T.J.; Lee, G.H. Paramagnetic nanoparticle T1 and T2 MRI contrast
agents. Phys. Chem. Chem. Phys. 2012, 14, 12687. [CrossRef] [PubMed]
8. Yu, M.; Huang, S.; Yu, K.J.; Clyne, A.M. Dextran and polymer polyethylene glycol (PEG) coating reduce
both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Int. J. Mol. Sci. 2012, 13,
5554–5570. [CrossRef] [PubMed]
9. Atabaev, T.S.; Lee, J.H.; Han, D.-W.; Kim, H.-K.; Hwang, Y.-H. Fabrication of carbon coated gadolinia particles
for dual-mode magnetic resonance and fluorescence imaging. J. Adv. Ceram. 2015, 4, 118–122. [CrossRef]
10. Atabaev, T.S.; Lee, J.H.; Han, D.W.; Choo, K.S.; Jeon, U.B.; Hwang, J.Y.; Yeom, J.A.; Kang, C.; Kim, H.K.;
Hwang, Y.H. Multicolor nanoprobes based on silica-coated gadolinium oxide nanoparticles with highly
reduced toxicity. RSC Adv. 2016, 6, 19758–19762. [CrossRef]
11. Tesch, A.; Wenisch, C.; Herrmann, K.H.; Reichenbach, J.R.; Warncke, P.; Fischer, D.; Müller, F.A.
Luminomagnetic Eu3+- and Dy3+-doped hydroxyapatite for multimodal imaging. Mater. Sci. Eng. C
2017, 81, 422–431. [CrossRef] [PubMed]
12. Atabaev, T.S. Paramagnetic Gd-doped zirconia nanoparticles for potential T1-weighted MRI imaging.
Nano Life 2017, 7, 1750007. [CrossRef]
13. Ren, X.Y.; Yuan, X.X.; Wang, Y.P.; Liu, C.L.; Qin, Y.; Guo, L.P.; Liu, L.H. Facile preparation of Gd3+
doped carbon quantum dots: Photoluminescence materials with magnetic resonance response as magnetic
resonance/fluorescence bimodal probes. Opt. Mater. 2016, 57, 56–62. [CrossRef]
14. Yu, C.; Xuan, T.; Chen, Y.; Zhao, Z.; Liu, X.; Lian, G.; Li, H. Gadolinium-doped carbon dots with high
quantum yield as an effective fluorescence and magnetic resonance bimodal imaging probe. J. Alloys Compd.
2016, 688, 611–619. [CrossRef]
15. Briley-Saebo, K.; Bjørnerud, A.; Grant, D.; Ahlstrom, H.; Berg, T.; Kindberg, G.M. Hepatic cellular distribution
and degradation of iron oxide nanoparticles following single intravenous injection in rats: Implications for
magnetic resonance imaging. Cell Tissue Res. 2004, 316, 315–323. [CrossRef] [PubMed]
16. Atabaev, T.S.; Shin, Y.C.; Song, S.-J.; Han, D.-W.; Hong, N.H. Toxicity and T2-weighted magnetic resonance
imaging potentials of holmium oxide nanoparticles. Nanomaterials 2017, 7, 216. [CrossRef] [PubMed]
17. Liang, Q.; Ma, W.; Shi, Y.; Li, Z.; Yang, X. Easy synthesis of highly fluorescent carbon quantum dots from
gelatin and their luminescent properties and applications. Carbon 2013, 60, 421–428. [CrossRef]
18. Zhou, J.; Shan, X.; Ma, J.; Gu, Y.; Qian, Z.; Chen, J.; Feng, H. Facile synthesis of P-doped carbon quantum
dots with highly efficient photoluminescence. RSC Adv. 2014, 4, 5465. [CrossRef]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
